In Vivo and In Vitro Protective Effects of Pentamethylquercetin on Cardiac Hypertrophy
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In Vivo and In Vitro Protective Effects of Pentamethylquercetin on Cardiac Hypertrophy
Authors
Keywords
-
Journal
CARDIOVASCULAR DRUGS AND THERAPY
Volume 26, Issue 2, Pages 109-120
Publisher
Springer Nature
Online
2011-12-20
DOI
10.1007/s10557-011-6363-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structural requirements of flavonoids for the adipogenesis of 3T3-L1 cells
- (2011) Hisashi Matsuda et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Suppressive effects of methoxyflavonoids isolated from Kaempferia parviflora on inducible nitric oxide synthase (iNOS) expression in RAW 264.7 cells
- (2011) Chutha Sae-Wong et al. JOURNAL OF ETHNOPHARMACOLOGY
- Regulation of adipocytokine secretion and adipocyte hypertrophy by polymethoxyflavonoids, nobiletin and tangeretin
- (2011) Yoshiki Miyata et al. LIFE SCIENCES
- Selective inhibition of methoxyflavonoids on human CYP1B1 activity
- (2010) Hitomi Takemura et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Tetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species-dependent ERK1/2 signalling
- (2010) Di-Fei Shen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Sirt1 acts in association with PPAR to protect the heart from hypertrophy, metabolic dysregulation, and inflammation
- (2010) A. Planavila et al. CARDIOVASCULAR RESEARCH
- Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart
- (2010) E. E. Creemers et al. CARDIOVASCULAR RESEARCH
- Temporal alterations in cardiac fibroblast function following induction of pressure overload
- (2010) James A. Stewart et al. CELL AND TISSUE RESEARCH
- Activation of SUR2B/Kir6.1 Subtype of Adenosine Triphosphate-sensitive Potassium Channel Improves Pressure Overload-induced Cardiac Remodeling via Protecting Endothelial Function
- (2010) Yuan Tang et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Activation of PPARγ by pioglitazone does not attenuate left ventricular hypertrophy following aortic banding in rats
- (2010) Celine S. Weiss et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Detection of Left Ventricular Hypertrophy in Rats Administered a Peroxisome Proliferator–Activated Receptor α/γ Dual Agonist Using Natriuretic Peptides and Imaging
- (2010) Steven K. Engle et al. TOXICOLOGICAL SCIENCES
- The peroxisome proliferator-activated receptor-α (PPAR-α) agonist, AVE8134, attenuates the progression of heart failure and increases survival in rats
- (2009) Wolfgang Linz et al. ACTA PHARMACOLOGICA SINICA
- Identification of nobiletin, a polymethoxyflavonoid, as an enhancer of adiponectin secretion
- (2009) Kazuhiro Kunimasa et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- 3,3′,4′,5,7-Pentamethylquercetin reduces angiotensin II-induced cardiac hypertrophy and apoptosis in rats
- (2009) Zhangfan Mao et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- KATP activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function
- (2009) S. Gao et al. CARDIOVASCULAR RESEARCH
- Defective peroxisomal proliferators activated receptor gamma activity due to dominant-negative mutation synergizes with hypertension to accelerate cardiac fibrosis in mice
- (2009) Adrienn Kis et al. EUROPEAN JOURNAL OF HEART FAILURE
- PPARδ activation inhibits angiotensin II induced cardiomyocyte hypertrophy by suppressing intracellular Ca2+signaling pathway
- (2009) Kuy-Sook Lee et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Molecular targets and regulators of cardiac hypertrophy
- (2009) Agrawal Rohini et al. PHARMACOLOGICAL RESEARCH
- Cardiac fibroblasts: At the heart of myocardial remodeling
- (2009) Karen E. Porter et al. PHARMACOLOGY & THERAPEUTICS
- Cardiac hypertrophy is enhanced in PPAR -/- mice in response to chronic pressure overload
- (2008) P. J.H. Smeets et al. CARDIOVASCULAR RESEARCH
- TNF-α reduces PGC-1α expression through NF-κB and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model
- (2008) Xavier Palomer et al. CARDIOVASCULAR RESEARCH
- Parallel up-regulation of FGF-2 and hyaluronan during development of cardiac hypertrophy in rat
- (2008) Urban Hellman et al. CELL AND TISSUE RESEARCH
- Suppression of Cardiac Myocyte Hypertrophy by Conjugated Linoleic Acid
- (2008) Caroline P. Alibin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inflammatory Pathways Are Activated during Cardiomyocyte Hypertrophy and Attenuated by Peroxisome Proliferator-activated Receptors PPARα and PPARδ
- (2008) Pascal J. H. Smeets et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effects and mechanisms of PPARα activator fenofibrate on myocardial remodelling in hypertension
- (2008) Chuan-Bao Li et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Novel Experimental Model of Pressure Overload Hypertrophy in Rats
- (2008) Ezequiel J. Molina et al. JOURNAL OF SURGICAL RESEARCH
- Transcriptomic analysis of PPARα-dependent alterations during cardiac hypertrophy
- (2008) Pascal J. H. Smeets et al. PHYSIOLOGICAL GENOMICS
- All-trans retinoic acid prevents development of cardiac remodeling in aortic banded rats by inhibiting the renin-angiotensin system
- (2007) Rashmi Choudhary et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- A citrus polymethoxyflavonoid, nobiletin, is a novel MEK inhibitor that exhibits antitumor metastasis in human fibrosarcoma HT-1080 cells
- (2007) Yoshiki Miyata et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now